Asia-Pacific Neonatal Jaundice Management Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Mar 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 144
  • No of Figures: 43

Asia-Pacific Neonatal Jaundice Management Market, By Management (Diagnosis, Treatment), Type (Primary Care, Secondary Care), Technology (Light-Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic, Others), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Users, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distribution), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2028

Asia-Pacific Neonatal Jaundice Management MarketMarket Analysis and Insights: Asia-Pacific Neonatal Jaundice Management Market

The neonatal jaundice management market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.2% in the forecast period of 2021 to 2028 and is expected to reach USD 117.49 million by 2028. The rising number of neonatal jaundice patients and technological advancement for disease testing and treatment are the major drivers which propelled the demand of the neonatal jaundice management market in the forecast period. 

The term jaundice is derived from the French word ‘jaune’ which means yellow. Neonatal jaundice is characterized by the appearance of yellowish color in skin as well as eyes (sclera and conjunctiva). It is one of the most common diseases in newborns that occur in the first week of after birth. It occurs mainly in 60% of term and 80% of preterm infant.

The increase in number of preterm births especially in Asia region require extra treatment for jaundice and these babies have to stay in the hospital under the care of physician and should be monitored daily which may increase the neonatal jaundice management market growth. The less adoption of the neonatal jaundice management treatment and diagnosis especially in low-income countries may act as a restraint for the neonatal jaundice management market growth. The increasing healthcare expenditure can lead to advancement in technologies and increase in the treatment options which may act as an opportunity for the growth of the neonatal jaundice management market. The complications related with the neonatal jaundice are the challenging factor for the patient population as well as the researchers and physicians in the neonatal jaundice management market. 

The neonatal jaundice management market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Neonatal Jaundice Management MarketAsia-Pacific Neonatal Jaundice Management Market Scope and Market Size

The neonatal jaundice management market is segmented on the basis of the management, type, technology, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of management, the neonatal jaundice management market is segmented into treatment and diagnosis. In 2021, diagnosis segment is expected to dominate the neonatal jaundice management market because of rising prevalence of neonatal jaundice and neonatal jaundice diagnosis which is mandatory for every child.
  • On the basis of type, the neonatal jaundice management market is segmented into primary care and secondary care. In 2021, primary care segment is expected to dominate the neonatal jaundice management market because primary care is the common and initial criteria for the neonatal infant care suffering from jaundice.
  • On the basis of technology, the neonatal jaundice management market is segmented into fluorescent, halogen, fiberoptic, light-emitting diode light sources and others. In 2021, light-emitting diode light sources segment is expected to dominate the neonatal jaundice management market as most of the healthcare facilities have LED based products and these products are highly effective.
  • On the basis of end user, the neonatal jaundice management market is segmented into hospitals, clinics, ambulatory surgical centers, home users and others. In 2021, hospitals segment is dominating the neonatal jaundice management market because of presence of highly specialized professional and presence of well-equipped technology for the treatment of neonatal jaundice.
  • On the basis of distribution channel, the neonatal jaundice management market is segmented into direct tender, retail sales and third party distribution. In 2021, direct tender segment is expected to dominate the neonatal jaundice management market because phototherapy devices or equipment are costly which required multiple vendor analysis for the purchase of device.

Neonatal Jaundice Management Market Country Level Analysis

The neonatal jaundice management market is analyzed and market size information is provided by the country, management, type, technology, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific neonatal jaundice management market report are the Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, and Rest of Asia-Pacific.

Diagnosis segment in Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increase in prevalence of neonatal jaundice in the region. China is leading the growth of the Asia-Pacific neonatal jaundice management market and treatment segment is dominating in this country due to technological advancement for the diagnosis and treatment of jaundice.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Technological Advancement and Effective Phototherapy Treatment are boosting the Neonatal Jaundice Management Market Growth

The neonatal jaundice management market also provides you with detailed market analysis for every country growth in neonatal jaundice management industry with neonatal jaundice management drugs sales, impact of advancement in the neonatal jaundice management technology and changes in regulatory scenarios with their support for the neonatal jaundice management market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Neonatal Jaundice Management Market Share Analysis

The neonatal jaundice management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to neonatal jaundice management market.

The major companies which are dealing in the Asia-Pacific neonatal jaundice management market report are Atom Medical Corp., avihealthcare, Ibis Medical, nice Neotech Medical Systems Pvt. Ltd., Phoenix Medical Systems (P) Ltd, Zhengzhou Dison Instrument And Meter Co., Ltd, Natus Medical Incorporated, Ardo, DAVID, Signify Holding, GE Healthcare (a subsidiary of General Electric Company), Drägerwerk AG & Co. KGaA , S S TECHNOMED(P)LTD, Herbert Waldmann GmbH & Co. KG, Shvabe‑Zurich GmbH, GINEVRI srl among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the neonatal jaundice management market.

For instance,

  • In December 2020, Neolight had increased USD 7 million in financing for the product Skylife, Dignity Health and Honor Health Systems helped the company financially. The product was initially for the hospital purpose but now the product was for the parents who can take the product to the home and can be easily used the consumer without need of physician. This helped the company to increase the market sale of the product in coming future.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company market in the neonatal jaundice management market which also provides the benefit for organization to improve their offering for neonatal jaundice management.

Customization Available: Asia-Pacific Neonatal Jaundice Management Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 REGULATION IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS

TABLE 2 RISK FACTORS FOR NEONATAL JAUNDICE

TABLE 3 CHARACTERISTICS OF TERM AND PRETERM INFANTS

TABLE 4 HEALTHCARE EXPENDITURE IN ASIA

TABLE 5 QUESTIONNAIRE FOR THE ONLINE FOLLOW-UP

TABLE 6 TIME SCHEDULE OF ONLINE FOLLOW-UP AFTER DISCHARGE

TABLE 7 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC PRIMARY CARE IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC SECONDARY CARE IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC LIGHT-EMITTING DIODE LIGHT SOURCES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC FIBEROPTIC IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC FLUORESCENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC HALOGEN IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC HOSPITALS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC CLINICS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC HOME USERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC OTHERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC DIRECT TENDERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, REGION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC RETAIL SALES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC THIRD PARTY DISTRIBUTION IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 44 CHINA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 45 CHINA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 46 CHINA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 47 CHINA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 48 CHINA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 49 CHINA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 50 CHINA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 CHINA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 52 CHINA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 CHINA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 JAPAN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 55 JAPAN DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 56 JAPAN TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 57 JAPAN TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 58 JAPAN TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 59 JAPAN TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 60 JAPAN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 JAPAN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 62 JAPAN NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 63 JAPAN NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 64 INDIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 65 INDIA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 66 INDIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 67 INDIA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 68 INDIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 69 INDIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 70 INDIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 71 INDIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 72 INDIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 INDIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 74 AUSTRALIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 75 AUSTRALIA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 76 AUSTRALIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 77 AUSTRALIA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 78 AUSTRALIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 79 AUSTRALIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 80 AUSTRALIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 AUSTRALIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 82 AUSTRALIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 83 AUSTRALIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 84 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 85 SOUTH KOREA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 86 SOUTH KOREA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 87 SOUTH KOREA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 88 SOUTH KOREA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 89 SOUTH KOREA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 92 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 93 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 94 SINGAPORE NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 95 SINGAPORE DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 96 SINGAPORE TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 97 SINGAPORE TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 98 SINGAPORE TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 99 SINGAPORE TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 100 SINGAPORE NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 101 SINGAPORE NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 102 SINGAPORE NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 103 SINGAPORE NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 104 MALAYSIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 105 MALAYSIA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 106 MALAYSIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 107 MALAYSIA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 108 MALAYSIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 109 MALAYSIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 MALAYSIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 MALAYSIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 112 MALAYSIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 113 MALAYSIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 114 THAILAND NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 115 THAILAND DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 116 THAILAND TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 117 THAILAND TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 118 THAILAND TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 119 THAILAND TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 THAILAND NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 THAILAND NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 122 THAILAND NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 123 THAILAND NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 124 INDONESIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 125 INDONESIA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 126 INDONESIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 127 INDONESIA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 128 INDONESIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 129 INDONESIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 130 INDONESIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 131 INDONESIA NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 132 INDONESIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 133 INDONESIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 134 PHILIPPINES NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 135 PHILIPPINES DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 136 PHILIPPINES TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 137 PHILIPPINES TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 138 PHILIPPINES TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)

TABLE 139 PHILIPPINES TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 140 PHILIPPINES NEONATAL JAUNDICE MANAGEMENTMARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 141 PHILIPPINES NEONATAL JAUNDICE MANAGEMENTMARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 142 PHILIPPINES NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 143 PHILIPPINES NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 144 REST OF ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions